FDA video on erlotinib (Tarceva) adverse effects
FDA video warning on gastrointestinal dermatologic and ophthalmic side effects of erlotinib (Tarceva).
Nilotinib (Tasigna) for chonic myeloid leukemia: Health Canada evaluation
Information from Health Canada issued October 14, 2008 about the recently approval of nilotinib (Tasugna) On September 9, 2008, Health Canada issued a Notice of Compliance under the Notice of Compliance with Conditions (NOC/c) Policy to Novartis Pharmaceuticals Canada Inc. for the drug product Tasigna*. The product was authorized under the NOC/c Policy on the […]